Category: by subject

A convicted felon writes a paper on hotly debated diets. What could go wrong?

Richard Fleming

Pro-tip for journals and publishers: When you decide to publish a paper about a subject — say, diets — that you know will draw a great deal of scrutiny from vocal proponents of alternatives, make sure it’s as close to airtight as possible.

And in the event that the paper turns out not to be so airtight, write a retraction notice that’s not vague and useless.

Oh, and make sure the lead author of said study isn’t a convicted felon who pleaded guilty to healthcare fraud.

If only we were describing a hypothetical. Continue reading A convicted felon writes a paper on hotly debated diets. What could go wrong?

Judge dismisses most of Carlo Croce’s libel case against the New York Times

Carlo Croce

Carlo Croce, a prolific cancer researcher at The Ohio State University in Columbus who was the subject of a front page story in The New York Times last year about allegations of misconduct against him, has had most of a lawsuit he filed against the newspaper thrown out.

As first reported by Courthouse News Service, United States District Judge James Graham tossed all but one of Croce’s claims for defamation against the Times and two of its reporters. That claim — which involved a statement in a letter that reporter James Glanz sent Croce as part of his reporting — survived dismissal, but not on grounds that it inflicted emotional distress, Graham ruled.

The March 2017 story ran on the front page of the Times under the headline “Years of Ethics Charges, but Star Cancer Researcher Gets a Pass:” Continue reading Judge dismisses most of Carlo Croce’s libel case against the New York Times

Data mishap forces retraction of paper on gun laws, domestic killings

The authors of a 2018 paper on the effects of gun laws on domestic violence have retracted the article after discovering errors in their analysis and replaced it with a clean version. The new study shows that some gun laws — particularly ones that keep firearms out of the hands of violent offenders, even if their offenses don’t involve domestic assaults — do seem to reduce the incidence of domestic killings.

The paper, which appeared last November in the American Journal of Epidemiology and received some press coverage, including this piece in the New York Times, looked specifically at whether laws that keep guns away from people convicted of violent crimes beyond domestic abuse reduce the number of intimate partner homicides. It also considered the effect of laws that covered dating partners and not simply spouses or former spouses. The first author is April Zeoli, of Michigan State University. Zeoli has published other papers on the topic and delivered a TEDMED talk on it as well.

According to the abstract of the article: Continue reading Data mishap forces retraction of paper on gun laws, domestic killings

Aerospace researchers in Japan up to three retractions

Rachid Amrousse

A pair of researchers in Japan has lost their third paper in a UK journal, which cites problematic images and an institutional investigation for the move.

The 2016 article, “Novel Rh-substituted hexaaluminate catalysts for N2O decomposition,” was written by Rachid Amrousse and Akimasa Tsutsumi, of the Japan Aerospace Exploration Agency, or JAXA, in Sagamihara. It appeared in Catalysis Society & Technology, a publication of the Royal Society of Chemistry, and has been cited seven times, according to Clarivate Analytics’ Web of Science.

According to the retraction notice: Continue reading Aerospace researchers in Japan up to three retractions

Caveat scriptor: How a journal editor unraveled the mystery of the overlapping bad data

John Loadsman

Caveat scriptor—writer beware.

That’s the moral of a recent editorial in the Saudi Journal of Anesthesia, prompted by the retraction in that journal of a 2014 paper with bum data.

The editorial was written by John Loadsman, an anesthesiologist in Sydney, Australia, and editor of the journal Anaesthesia and Intensive Care, who played a role in the retraction. Here’s how.

According to Loadsman, he was considering an article for his journal — a meta-analysis of previously published findings. On inspection, he he noticed that some of the studies cited in the meta-analysis were potentially problematic, including Continue reading Caveat scriptor: How a journal editor unraveled the mystery of the overlapping bad data

The “regression to the mean project:” What researchers should know about a mistake many make

David Allison, via IU

The work of David Allison and his colleagues may be familiar to Retraction Watch readers. Allison was the researcher — then at the University of Alabama, Birmingham, now at Indiana University — who led an effort to correct the nutrition literature a few years ago. He and his colleagues are back, this time with what might be called the “Regression to the Mean Project,” an attempt to fix a problem that seems to vex many clinical trials. You may have noticed some items in Weekend Reads about letters to the editor that mention the issue. Here, Allison explains.

•Retraction Watch (RW): First, what is “regression to the mean,” and what does it mean for clinical studies? Continue reading The “regression to the mean project:” What researchers should know about a mistake many make

“Sufficiently serious” issues in study prompt company to yank drug approval application in China

The maker of a leading over-the-counter antacid has withdrawn its application for approval of the drug in China because a clinical trial of the product in that country was marred by “major protocol deviations.”

Researchers for the company, Reckitt Benckiser, maker of Gaviscon, had published a report on the study in 2015 in the journal Alimentary Pharmacology & Therapeutics. But the journal has now retracted the article, “Randomised clinical trial: The clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China,” at the behest of the drug maker.

According to the notice: Continue reading “Sufficiently serious” issues in study prompt company to yank drug approval application in China

Harvard and the Brigham recommend 31 retractions for cardiac stem cell work

Piero Anversa

Retraction Watch readers may be familiar with the name Piero Anversa. Until several years ago, Anversa, a scientist at Harvard Medical School and the Brigham and Women’s Hospital, was a powerful figure in cardiac stem cell research.

“For ten years, he ran everything,” says Jeffery Molkentin, a researcher at Cincinnati Children’s whose lab was among the first to question the basis of Anversa’s results in a 2014 paper in Nature. Continue reading Harvard and the Brigham recommend 31 retractions for cardiac stem cell work

Four years after readers raise concerns, journal finally retracts climate paper

The wheels of scientific publishing turn slowly … but they do (sometimes) turn.

In January, we reported on the case of a paper on global warming marred by several problems, including allegations of plagiarism and “false claims” by the authors — which readers had raised as early as 2014, with no result. (Find a discussion of those allegations here.)

Now, the journal, Elsevier’s Renewable and Sustainable Energy Reviews (ironic on multiple levels, when you think about it), is retracting the paper.

According to the long-time-in-coming retraction notice: Continue reading Four years after readers raise concerns, journal finally retracts climate paper

What really happened when two mathematicians tried to publish a paper on gender differences? The tale of the emails

Quillette

Retraction Watch readers may be familiar with the story of a paper about gender differences by two mathematicians. Last month, in Weekend Reads, we highlighted an account of that story, which appeared in Quillette.

The piece, by one of the paper’s authors — titled “Academic Activists Send a Published Paper Down the Memory Hole” — touches on issues familiar to those who follow the culture wars, which isn’t all that surprising given the controversial topic, one once discussed by then-Harvard president Larry Summers.

The piece has generated a great deal of conversation, some of it quite heated, and a number of participants in those conversations have suggested that seeing the emails that the author of the Quillette piece says support his account would be useful. That’s what this post is mostly designed to do: Surface those emails. Continue reading What really happened when two mathematicians tried to publish a paper on gender differences? The tale of the emails